{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:22:03Z","timestamp":1783405323630,"version":"3.54.6"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"7","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1ZIABC011846"],"award-info":[{"award-number":["1ZIABC011846"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children\u2019s National Hospital, Brain Tumor Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Approximately 12\u00a0000 adolescents and young adults (ages 15-39, AYAs) are diagnosed with a primary central nervous system (CNS) tumor each year. DNA methylation profiling has transformed CNS tumor classification by refining diagnostic accuracy and identifying biologically distinct subtypes, but its application has not been systematically evaluated in the AYA population. In this study, we examined the spectrum of CNS tumor types across age groups, with a focus on the AYA population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assembled a large dataset of CNS tumor samples with age annotations and methylation profiles matching with high confidence to a CNS tumor type using the NCI\/Bethesda classifier. Prevalence of tumor type, methylation class and DNA copy number aberrations were compared across age strata (pediatric, AYA, and adult).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort of 21\u00a0712 CNS tumors included 5351 tumors from AYAs (25%), which showed a mixed pattern, with tumors typical of childhood (eg, medulloblastoma) as well as those common in older adults (eg, glioblastoma). Several tumor types were specifically enriched in the AYA, including IDH-mutant astrocytoma, pleomorphic xanthoastrocytoma, posterior fossa group B ependymoma, and diffuse hemispheric glioma, H3 G34-mutant, among others. Distinct methylation subclasses of multiple tumor types were observed in the AYA, and patterns of genomic aberrations showed age-specific distributions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Large-scale methylation profiling revealed unique classification patterns of CNS tumors in AYAs, with specific tumor types, subclasses, and genomic alterations enriched in this population. These data may serve as a valuable reference resource for better understanding the spectrum of CNS tumors affecting AYA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag082","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:39:16Z","timestamp":1775907556000},"page":"1808-1820","source":"Crossref","is-referenced-by-count":0,"title":["CNS tumor type prevalence according to age group: An analysis of 21\u00a0000 cases confirmed by methylation profiling, with a focus on adolescents and young adults"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-6833","authenticated-orcid":false,"given":"Adriana","family":"Fonseca","sequence":"first","affiliation":[{"name":"Brain Tumor Institute, Children\u2019s National Hospital , Washington, District of Columbia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeor","family":"Yefet","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic , Rochester, Minnesota,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-7519","authenticated-orcid":false,"given":"Omkar","family":"Singh","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-6462","authenticated-orcid":false,"given":"Christopher","family":"Dampier","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1357-2384","authenticated-orcid":false,"given":"Karen","family":"Dazelle","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2167-506X","authenticated-orcid":false,"given":"Michelle","family":"Lam","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6345-2088","authenticated-orcid":false,"given":"Zied","family":"Abdullaev","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jung","family":"Chung","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0941-8662","authenticated-orcid":false,"given":"Martha","family":"Quezado","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-6957","authenticated-orcid":false,"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-9969","authenticated-orcid":false,"given":"Jeffrey","family":"Gagan","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-6395","authenticated-orcid":false,"given":"Ina","family":"Lee","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-0898","authenticated-orcid":false,"given":"MacLean","family":"Nasrallah","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4146-1511","authenticated-orcid":false,"given":"Julie","family":"Bennett","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre , Toronto, Ontario,","place":["Canada"]},{"name":"Division of Hematology\/Oncology, Hospital for Sick Children , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6832-6539","authenticated-orcid":false,"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Hospital for Sick Children , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-4160","authenticated-orcid":false,"given":"Dipak","family":"Poria","sequence":"additional","affiliation":[{"name":"Brain Tumor Institute, Children\u2019s National Hospital , Washington, District of Columbia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-5201","authenticated-orcid":false,"given":"Pieter","family":"Wesseling","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam University Medical Centers\/VU University Medical Center , Amsterdam,","place":["The Netherlands"]},{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht, (P.W.)","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-5127","authenticated-orcid":false,"given":"Martin","family":"van den Bent","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus MC Cancer Institute , Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0774-7700","authenticated-orcid":false,"given":"Patrick Y","family":"Wen","sequence":"additional","affiliation":[{"name":"Mass General Brigham Cancer Institute Center for Tumors of the Nervous System, , Boston, Massachusetts, (P.Y.W.)","place":["USA"]},{"name":"Harvard Medical School Neurology, , Boston, Massachusetts, (P.Y.W.)","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-1517","authenticated-orcid":false,"given":"Pascale","family":"Varlet","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, GHU Paris \u2013 Psychiatry and Neuroscience, Sainte-Anne Hospital , Paris,","place":["France"]},{"name":"Universit\u00e9 de Paris, UMR S1266, INSERM, IMA-BRAIN, Institute of Psychiatry and Neurosciences of Paris , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-0297","authenticated-orcid":false,"given":"Arnault","family":"Tauzi\u00e8de-Espariat","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, GHU Paris \u2013 Psychiatry and Neuroscience, Sainte-Anne Hospital , Paris,","place":["France"]},{"name":"Universit\u00e9 de Paris, UMR S1266, INSERM, IMA-BRAIN, Institute of Psychiatry and Neurosciences of Paris , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-2913","authenticated-orcid":false,"given":"Cristiane M","family":"Ida","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2002-5313","authenticated-orcid":false,"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic , Rochester, Minnesota,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7550","authenticated-orcid":false,"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]},{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2026070701512440400_noag082-B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3322\/caac.21585","article-title":"Adolescent and young adult oncology-past, present, and future","volume":"69","author":"Close","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2026070701512440400_noag082-B2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrclinonc.2015.92","article-title":"Adolescent and young adult patients with cancer: a milieu of unique features","volume":"12","author":"Sender","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2026070701512440400_noag082-B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.26861","article-title":"Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology","volume":"65","author":"Zapotocky","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2026070701512440400_noag082-B4","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B5","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00401-025-02873-8","article-title":"Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients","volume":"149","author":"Singh","year":"2025","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of Central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"2026070701512440400_noag082-B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","article-title":"Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience","volume":"136","author":"Capper","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/neuonc\/noab227","article-title":"Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics","volume":"24","author":"Wu","year":"2022","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-025-00962-x","article-title":"A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis","volume":"6","author":"Bennett","year":"2025","journal-title":"Nat Cancer"},{"key":"2026070701512440400_noag082-B12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","article-title":"Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi","volume":"33","author":"Fortin","year":"2017","journal-title":"Bioinformatics"},{"key":"2026070701512440400_noag082-B13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-021-02354-8","article-title":"PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum","volume":"142","author":"Alhalabi","year":"2021","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00401-023-02558-0","article-title":"Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions","volume":"145","author":"Bogumil","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-022-02516-2","article-title":"Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification","volume":"145","author":"Keck","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/PAS.0000000000002118","article-title":"A novel type of IDH-wildtype glioma characterized by gliomatosis cerebri-like growth pattern, TERT promoter mutation, and distinct epigenetic profile","volume":"47","author":"Muench","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"2026070701512440400_noag082-B17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00401-022-02404-9","article-title":"High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13","volume":"143","author":"Pratt","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-024-02766-2","article-title":"Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations","volume":"148","author":"Sievers","year":"2024","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-021-02356-6","article-title":"Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors","volume":"142","author":"Sievers","year":"2021","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00401-022-02492-7","article-title":"Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases","volume":"144","author":"Sievers","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-022-02430-7","article-title":"DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival","volume":"144","author":"Wu","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00401-022-02508-2","article-title":"Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions","volume":"144","author":"Wu","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral heterogeneity within medulloblastoma subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"key":"2026070701512440400_noag082-B24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00401-013-1126-5","article-title":"Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays","volume":"125","author":"Hovestadt","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-012-1077-2","article-title":"DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies","volume":"125","author":"Schwalbe","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B26","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1016\/S1470-2045(19)30669-2","article-title":"EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma","volume":"20","author":"Franceschi","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026070701512440400_noag082-B27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040356","article-title":"Typical pediatric brain tumors occurring in adults-differences in management and outcome","volume":"9","author":"Greuter","year":"2021","journal-title":"Biomedicines"},{"key":"2026070701512440400_noag082-B28","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noae047","article-title":"CBTRUS statistical report: American Brain Tumor Association & NCI neuro-oncology branch adolescent and young adult primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/neuonc\/noae186","article-title":"Central nervous system tumors in adolescents and young adults: a society for neuro-oncology consensus review on diagnosis, management, and future directions","volume":"27","author":"Lim-Fat","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B30","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10&lt;2342::AID-CNCR19&gt;3.0.CO;2-X","article-title":"Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study","volume":"88","author":"Aldape","year":"2000","journal-title":"Cancer"},{"key":"2026070701512440400_noag082-B31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","article-title":"Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective","volume":"120","author":"van den Bent","year":"2010","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026070701512440400_noag082-B33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-019-02020-0","article-title":"Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of group 3 and group 4 subtypes","volume":"138","author":"Sharma","year":"2019","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B34","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/neuonc\/noab034","article-title":"Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q","volume":"23","author":"Baroni","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-018-1888-x","article-title":"Heterogeneity within the PF-EPN-B ependymoma subgroup","volume":"136","author":"Cavalli","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2026070701512440400_noag082-B36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature13108","article-title":"Epigenomic alterations define lethal CIMP-positive ependymomas of infancy","volume":"506","author":"Mack","year":"2014","journal-title":"Nature"},{"key":"2026070701512440400_noag082-B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40478-020-00973-y","article-title":"High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma","volume":"8","author":"Raffeld","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"2026070701512440400_noag082-B38","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/neuonc\/noad030","article-title":"Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment","volume":"25","author":"Trager","year":"2023","journal-title":"Neuro-oncology"},{"key":"2026070701512440400_noag082-B39","doi-asserted-by":"publisher","first-page":"e12894","DOI":"10.1111\/nan.12894","article-title":"DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification","volume":"49","author":"Stone","year":"2023","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026070701512440400_noag082-B40","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1002\/cncr.30884","article-title":"Malignant Central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US surveillance, epidemiology, and end results program: mortality and survival patterns","volume":"123","author":"Georgakis","year":"2017","journal-title":"Cancer"},{"key":"2026070701512440400_noag082-B41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/jayao.2020.0074","article-title":"Treatment and outcomes for Central nervous system tumors in Australian adolescents and young adults: a population-based national study","volume":"10","author":"Harrup","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2026070701512440400_noag082-B42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11060-018-2983-5","article-title":"A comparative analysis of clinicopathological features and survival among early adolescents\/young adults and children with low-grade glioma: a report from the children\u2019s oncology group","volume":"140","author":"Margol","year":"2018","journal-title":"J Neurooncol"},{"key":"2026070701512440400_noag082-B43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/neuonc\/noz227","article-title":"An epidemiology report for primary central nervous system tumors in adolescents and young adults: a nationwide population-based study in France, 2008-2013","volume":"22","author":"Ng","year":"2020","journal-title":"Neuro Oncol"},{"key":"2026070701512440400_noag082-B44","doi-asserted-by":"publisher","first-page":"e28970","DOI":"10.1002\/pbc.28970","article-title":"Racial\/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors","volume":"68","author":"Puthenpura","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"2026070701512440400_noag082-B45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/jayao.2024.0124","article-title":"Survival outcomes following chemotherapy for high-grade central nervous system tumors in adolescents and young adults: an exploration of variations according to ethnicity and deprivation","volume":"14","author":"Sciberras","year":"2025","journal-title":"J Adolesc Young Adult Oncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag082\/68077621\/noag082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/7\/1808\/68077621\/noag082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/7\/1808\/68077621\/noag082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:51:32Z","timestamp":1783403492000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/7\/1808\/8653739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4,13]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag082","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,13]]}}}